ZYNE stock continued to gain momentum in Friday’s session and was recently moving up by 10.36% to $8.53 USD, extending its winning streak for the fourth straight session. Shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE) are up over 55% since April 2nd, 2019, as the FDA has started looking into how it might legalize CBD-laced food products.
Earlier this week, the agency announced it will hold its first public hearings on CBD on May 31st.
Zygel Drives ZYNE StockThe FDA approving cannabis-laced food products is a step in the right direction, expected to validate Zynerba ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.